Early Pharmacotherapy Aimed at Neuroplasticity in Autism : Safety and Efficacy

Summary

The purpose of this study is to determine the efficacy, safety, and population pharmacokinetics and determinants of drug responses to buspirone in children with autism using a randomized, double blind, cross over study in children ages 2 to 6 years.

Timeline

Start

2004-03

Primary completion

—

Completion

2005-08

Drugs

Indications